DASAN Zhone Solutions Sets Fourth Quarter and Full Year 2019 Earnings Call for Thursday, March 5, 2020 at 5:00 p.m. ET
OAKLAND, Calif., Feb. 24, 2020 (GLOBE NEWSWIRE) — DASAN Zhone Solutions, Inc. (NASDAQ: DZSI or the “Company” or “DZS”), a […]
RigNet Announces Amendment and Extension of Credit Facility
HOUSTON, Feb. 24, 2020 (GLOBE NEWSWIRE) — RigNet (NASDAQ: RNET, the “Company”), the leading provider of ultra-secure, intelligent networking solutions, […]
Allakos Announces Multiple Presentations Related to Eosinophil and Mast Cell-Driven Diseases at the 2020 AAAAI Annual Meeting
REDWOOD CITY, Calif., Feb. 24, 2020 (GLOBE NEWSWIRE) — Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing antolimab […]
Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2019 Financial Results Conference Call and Webcast
NEW YORK, Feb. 24, 2020 (GLOBE NEWSWIRE) — Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of and […]
TRxADE GROUP, INC. Announces Exercise of Overallotment Option by Underwriters
TAMPA, FL, Feb. 24, 2020 (GLOBE NEWSWIRE) — Trxade Group, Inc., (Nasdaq: MEDS)(“Trxade Group” or the “Company”), an integrated drug […]
Neoleukin Therapeutics to Present at Cowen and Company 40th Annual Health Care Conference
SEATTLE, Feb. 24, 2020 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc. (“Neoleukin”) (Nasdaq: NLTX), a biopharmaceutical company utilizing sophisticated computational methods […]
Oyster Point Pharma to Present at the Cowen 40th Annual Healthcare Conference
PRINCETON, N.J., Feb. 24, 2020 (GLOBE NEWSWIRE) — Oyster Point Pharma, Inc. (Nasdaq: OYST), a clinical-stage biopharmaceutical company focused on […]
Catalyst Biosciences to Present at the Cowen Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Feb. 24, 2020 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc. (NASDAQ: CBIO), today announced that Nassim Usman, Ph.D., […]
MyoKardia to Present at 40th Annual Cowen Health Care Conference
BRISBANE, Calif., Feb. 24, 2020 (GLOBE NEWSWIRE) — MyoKardia, Inc. (Nasdaq: MYOK), today announced that Taylor Harris, Chief Financial Officer, […]
Zogenix to Release Fourth Quarter and Full-Year 2019 Financial Results and Host Conference Call and Webcast on March 2
EMERYVILLE, Calif., Feb. 24, 2020 (GLOBE NEWSWIRE) — Zogenix, Inc. (Nasdaq: ZGNX), a global pharmaceutical company developing rare disease therapies, […]
